Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 4
1994 1
1995 4
1996 5
1997 5
1998 4
2001 4
2002 5
2003 7
2004 3
2005 2
2006 5
2007 3
2008 12
2009 12
2010 12
2011 15
2012 15
2013 18
2014 21
2015 23
2016 23
2017 16
2018 9
2019 17
2020 15
2021 18
2022 17
2023 12
2024 6
2025 9
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Results by year

Filters applied: . Clear all
Page 1
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
Grinspoon SK, Fitch KV, Zanni MV, Fichtenbaum CJ, Umbleja T, Aberg JA, Overton ET, Malvestutto CD, Bloomfield GS, Currier JS, Martinez E, Roa JC, Diggs MR, Fulda ES, Paradis K, Wiviott SD, Foldyna B, Looby SE, Desvigne-Nickens P, Alston-Smith B, Leon-Cruz J, McCallum S, Hoffmann U, Lu MT, Ribaudo HJ, Douglas PS; REPRIEVE Investigators. Grinspoon SK, et al. N Engl J Med. 2023 Aug 24;389(8):687-699. doi: 10.1056/NEJMoa2304146. Epub 2023 Jul 23. N Engl J Med. 2023. Update in: N Engl J Med. 2024 May 2;390(17):1626-1628. doi: 10.1056/NEJMc2400870. PMID: 37486775 Free PMC article. Updated. Clinical Trial.
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysis.
Fichtenbaum CJ, Malvestutto CD, Watanabe MG, Davies Smith E, Ribaudo HJ, McCallum S, Fitch KV, Currier JS, Diggs MR, Chu SM, Aberg JA, Lu MT, Valencia J, Gómez-Ayerbe C, Brar I, Valdez Madruga J, Bloomfield GS, Douglas PS, Zanni MV, Grinspoon SK; REPRIEVE Investigators. Fichtenbaum CJ, et al. Lancet HIV. 2025 Jul;12(7):e496-e505. doi: 10.1016/S2352-3018(25)00043-8. Epub 2025 Jun 4. Lancet HIV. 2025. PMID: 40482662 Clinical Trial.
Viral pneumonia: etiologies and treatment.
Dandachi D, Rodriguez-Barradas MC. Dandachi D, et al. Among authors: rodriguez barradas mc. J Investig Med. 2018 Aug;66(6):957-965. doi: 10.1136/jim-2018-000712. Epub 2018 Apr 20. J Investig Med. 2018. PMID: 29680828 Review.
It's not that simple.
Chien KS, Farmakiotis D, Rodriguez-Barradas MC, Musher DM. Chien KS, et al. Among authors: rodriguez barradas mc. Clin Infect Dis. 2013 Jan;56(2):308. doi: 10.1093/cid/cis834. Epub 2012 Sep 28. Clin Infect Dis. 2013. PMID: 23024294 No abstract available.
Cancer immunotherapy in adult patients with HIV.
Abu Khalaf S, Dandachi D, Granwehr BP, Rodriguez-Barradas MC. Abu Khalaf S, et al. Among authors: rodriguez barradas mc. J Investig Med. 2022 Apr;70(4):883-891. doi: 10.1136/jim-2021-002205. Epub 2022 Jan 27. J Investig Med. 2022. PMID: 35086858 Review.
Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function.
Erlandson KM, Umbleja T, Ribaudo HJ, Schrack JA, Overton ET, Fichtenbaum CJ, Fitch KV, Roa JC, Diggs MR, Wood K, Zanni MV, Bloomfield GS, Malvestutto C, Aberg JA, Rodriguez-Barradas MC, Morones RG, Breaux K, Douglas PS, Grinspoon SK, Brown TT. Erlandson KM, et al. Among authors: rodriguez barradas mc. Clin Infect Dis. 2025 Feb 24;80(2):425-433. doi: 10.1093/cid/ciae422. Clin Infect Dis. 2025. PMID: 39159048 Free PMC article. Clinical Trial.
Postacute COVID-19: An Overview and Approach to Classification.
Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Amenta EM, et al. Among authors: rodriguez barradas mc. Open Forum Infect Dis. 2020 Oct 21;7(12):ofaa509. doi: 10.1093/ofid/ofaa509. eCollection 2020 Dec. Open Forum Infect Dis. 2020. PMID: 33403218 Free PMC article. Review.
Impact of High-Titer Convalescent Plasma on Clinical and Virologic Outcomes Among Veterans Hospitalized With SARS-CoV-2 Infection: VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1).
Janoff EN, Shih MC, Donskey C, Belitskaya-Levy I, Brau N, Rodriguez-Barradas MC, Chan E, Zimmerman P, Miller EK, Vaughan LB, Daniel Markley J, Goldberg AM, Sriram P, Anzueto A, Uyeda L, Zehm L, Wills A, Hutchinson C, Jones L, Peterson D, Ringer RJ, Dumont L, Gleason T, Bonomo RA, Curtis JL, Brown ST; CURES‐1 Trials Consortium. Janoff EN, et al. Among authors: rodriguez barradas mc. J Med Virol. 2025 May;97(5):e70349. doi: 10.1002/jmv.70349. J Med Virol. 2025. PMID: 40400480 Clinical Trial.
297 results